- Home
- IDCC vs RGC Comparison
IDCC vs RGC Comparison
Compare IDCC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDCC | RGC |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IDCC | RGC |
|---|---|---|
| Price | $329.29 | $28.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $412.50 | N/A |
| AVG Volume (30 Days) | 266.5K | ★ 974.7K |
| Earning Date | 02-05-2026 | 10-24-2025 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ 58.70 | N/A |
| EPS | ★ 14.75 | N/A |
| Revenue | ★ $928,587,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.50 | ★ N/A |
| Revenue Growth | ★ 28.75 | N/A |
| 52 Week Low | $177.00 | $0.09 |
| 52 Week High | $412.60 | $83.60 |
Technical Indicators
Market Signals| Indicator | IDCC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 50.52 |
| Support Level | $322.21 | $27.32 |
| Resistance Level | $338.00 | $33.98 |
| Average True Range (ATR) | 12.43 | 6.80 |
| MACD | 2.79 | -0.87 |
| Stochastic Oscillator | 75.10 | 27.50 |
Price Performance
Historical ComparisonAbout IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.